Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009

Journal of Acquired Immune Deficiency Syndromes

Volumn 54, Issue 2, 2010, Pages 191-196

  Zhou, Shuntai ^a   Zhao, Yan ^a   He, Yun ^b   Li, Huiqin ^c   Bulterys, Marc ^d   Sun, Xin ^a   Dou, Zhihui ^a   Robinson, Matthew ^e   Zhang, Fujie ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Henan Infectious Disease Hospital   (China)

^c Yunnan AIDS Care Center   (China)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (China)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Bloodborne transmission; Coinfection; Hepatitis B and C prevalence; Mother to child transmission; Pediatrics HIV

Indexed keywords

AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ARTICLE; BLOOD TRANSFUSION; CHILD; CHINA; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; SEROPREVALENCE; VIRAL CONTAMINATION; VIRUS TRANSMISSION;

AGE FACTORS; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; CHINA; CONFIDENCE INTERVALS; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES;

EID: 77953069925     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181c99226     Document Type: Article

References (32)

1. National AIDS Prevention and Treatment Data Information Seasonal Report. Beijing, China: National Center for AIDS/STD Control and Prevention, China CDC; 2008:1-2.
2. A Joint Assessmentof HIV/AIDS Prevention, Treatment and Care in China (2007). Beijing, China: State Council AIDS Working Committee Office, UN Theme Group on AIDS in China; 2007.
3. Zhang F, Au MC, Bouey PD, et al. The diagnosis and treatment of HIV-infected children in China: challenges and opportunities. J Acquir Immune Defic Syndr. 2007;44:429-434.
4. Zhang F, Haberer JE, Zhao Y, et al. Chinese pediatric highly active antiretroviral therapy observational cohort: a 1-year analysis of clinical, immunologic, and virologic outcomes. J Acquir Immune Defic Syndr. 2007;46:594-598.
5. Williams R. Global challenges in liver disease. Hepatology. 2006;44: 521-526.
6. Lianjie KLSYH. Studies on epidemiology of the population with HCV and HEV infections and their epidemic factors in China. Chin J Infect Dis. 1997;15:71-75.
7. Xia GLLC, Cao HL. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Int Hepatol Commun. 1996;5:62-73.
8. Ferrero S, Lungaro P, Bruzzone BM, et al. Prospective study of mother-to-infant transmission of hepatitis C virus: a 10-year survey (1990-2000). Acta Obstet Gynecol Scand. 2003;82:229-234.
9. Thomas DL, Villano SA, Riester KA, et al. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study. J Infect Dis. 1998;177: 1480-1488.
10. Papaevangelou V, Pollack H, Rochford G, et al. Increased transmission of vertical hepatitis C virus (HCV) infection to human immunodeficiency virus (HIV)-infected infants of HIV-and HCV-coinfected women. J Infect Dis. 1998;178:1047-1052.
11. Shepard CW, Finelli L, Fiore AE, et al. Epidemiology of hepatitis B and hepatitis B virus infection in United States children. Pediatr Infect Dis J. 2005;24:755-760.
12. England K, Thorne C, Newell ML. Vertically acquired paediatric coinfection with HIV and hepatitis C virus. Lancet Infect Dis. 2006;6:83-90.
13. Zhou J, Dore GJ, Zhang F, et al. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database. J Gastroenterol Hepatol. 2007;22:1510-1518.
14. Nigro G, D'Orio F, Catania S, et al. Mother to infant transmission of coinfection by human immunodeficiency virus and hepatitis C virus: prevalence and clinical manifestations. Arch Virol. 1997;142:453-457.
15. Shivraj SO, Chattopadhya D, Grover G, et al. Role of HCV coinfection towards disease progression and survival in HIV-1 infected children: a follow-up study of 10 years. J Trop Pediatr. 2006;52:206-211.
16. He N, Detels R. The HIV epidemic in China: history, response, and challenge. Cell Res. 2005;15:825-832.
17. Qian HZ, Vermund SH. Editorial commentary: antiretroviral therapy for former plasma donors in China: saving lives when HIV prevention fails. Clin Infect Dis. 15 2008;47:834-836.
18. Dawson B, Trapp R. Lange Biostatistics. New York: McGraw-Hill Professional Publishing; 2004.
19. Schuval S, Van Dyke RB, Lindsey JC, et al. Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocol. Arch Pediatr Adolesc Med. 2004;158: 1007-1013.
20. Toussi SS, Abadi J, Rosenberg M, et al. Prevalence of hepatitis B and C virus infections in children infected with HIV. Clin Infect Dis. 2007;45: 795-798.
21. Telatela SP, Matee MI, Munubhi EK. Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania. BMC Public Health. 2007;7:338.
22. Progress in hepatitis B prevention through universal infant vaccination - China, 1997-2006. MMWR Morb Mortal Wkly Rep. 2007;56:441-445.
23. Liang X, Bi S, Yang W, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis. 2009;200:39-47.
24. Chamot E, Hirschel B, Wintsch J, et al. Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users. AIDS. 1990; 4:1275-1277.
25. Thio CL, Nolt KR, Astemborski J, et al. Screening for hepatitis C virus in human immunodeficiency virus-infected individuals. J Clin Microbiol. 2000;38:575-577.
26. Mast EE, Hwang LY, Seto DS, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis. 2005;192:1880-1889.
27. Rerksuppaphol S, Hardikar W, Dore GJ. Long-term outcome of vertically acquired and post-transfusion hepatitis C infection in children. J Gastroenterol Hepatol. 2004;19:1357-1362.
28. England K, Pembrey L, Tovo PA, et al. Growth in the first 5 years of life is unaffected in children with perinatally-acquired hepatitis C infection. J Pediatr. 2005;147:227-232.
29. Resti M, Jara P, Hierro L, et al. Clinical features and progression of perinatally acquired hepatitis C virus infection. J Med Virol. 2003;70: 373-377. (Pubitemid 36638049)
30. Newell ML, Coovadia H, Cortina-Borja M, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004;364:1236-1243.
31. Xu WM, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat. 2009; 16:94-103.
32. Blood Products Regulation Act. Central People's Government of the People's Republic of China; 1996.